CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma
出版年份 2016 全文链接
标题
CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma
作者
关键词
-
出版物
OncoImmunology
Volume 5, Issue 6, Pages e1151594
出版商
Informa UK Limited
发表日期
2016-03-11
DOI
10.1080/2162402x.2016.1151594
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Novel Insights into Head and Neck Cancer using Next-Generation "Omic" Technologies
- (2015) L. Sepiashvili et al. CANCER RESEARCH
- CTLA-4+Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
- (2015) Hyun-Bae Jie et al. CANCER RESEARCH
- Progesterone protects endothelial cells after cerebrovascular occlusion by decreasing MCP-1- and CXCL1-mediated macrophage infiltration
- (2015) Ebony Washington Remus et al. EXPERIMENTAL NEUROLOGY
- Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade
- (2015) Elizabeth Buchbinder et al. JOURNAL OF CLINICAL INVESTIGATION
- Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer – Review of current data
- (2015) Mark S. Swanson et al. ORAL ONCOLOGY
- Macrophages and cancer: from mechanisms to therapeutic implications
- (2015) Renato Ostuni et al. TRENDS IN IMMUNOLOGY
- Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
- (2015) Simona Partlová et al. OncoImmunology
- Characterization of thein vivoimmune network of IDO, tryptophan metabolism, PD-L1, andCTLA-4in circulating immune cells in melanoma
- (2015) I Chevolet et al. OncoImmunology
- The head and neck cancer cell oncogenome: A platform for the development of precision molecular therapies
- (2015) Daniel Martin et al. Oncotarget
- The origin and function of tumor-associated macrophages
- (2014) Yang Liu et al. Cellular & Molecular Immunology
- Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2014) D. T. Weed et al. CLINICAL CANCER RESEARCH
- IL-1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer
- (2014) Chia-Huei Lee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD163+ Tumor-Associated Macrophages Correlated with Poor Prognosis and Cancer Stem Cells in Oral Squamous Cell Carcinoma
- (2014) Ke-Fei He et al. Biomed Research International
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
- (2013) S. Lyford-Pike et al. CANCER RESEARCH
- Tumor associated macrophages and neutrophils in cancer
- (2013) Maria Rosaria Galdiero et al. IMMUNOBIOLOGY
- T-cell co-stimulation by CD28–CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development
- (2013) M.M. Ewing et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Immune Signature of CD8+CCR7+ T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC
- (2012) M. Czystowska et al. CLINICAL CANCER RESEARCH
- Chemopreventive and Chemotherapeutic Actions of mTOR Inhibitor in Genetically Defined Head and Neck Squamous Cell Carcinoma Mouse Model
- (2012) Z.-J. Sun et al. CLINICAL CANCER RESEARCH
- Myeloid-derived suppressor cells in transplantation and cancer
- (2012) Jordi C. Ochando et al. IMMUNOLOGIC RESEARCH
- Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer
- (2012) Charles C. L. Tong et al. IMMUNOLOGIC RESEARCH
- Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer
- (2012) Sokratis Trellakis et al. Innate Immunity
- Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms
- (2011) Jingjing Quan et al. CANCER AND METASTASIS REVIEWS
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
- (2011) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Re-educating tumour-associated macrophages
- (2011) Alexandra Flemming NATURE REVIEWS DRUG DISCOVERY
- Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation
- (2011) Y Bian et al. ONCOGENE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma
- (2010) Karl S Peggs et al. Expert Review of Anticancer Therapy
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
- (2009) M. Hashibe et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CD28 and CTLA-4 coreceptor expression and signal transduction
- (2009) Christopher E. Rudd et al. IMMUNOLOGICAL REVIEWS
- PD-1 and CTLA-4 Inhibitory Cosignaling Pathways in HIV Infection and the Potential for Therapeutic Intervention
- (2009) Daniel E. Kaufmann et al. JOURNAL OF IMMUNOLOGY
- Macrophage polarization in tumour progression
- (2008) Antonio Sica et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started